Evidence map›Paper›PMID 25888895›Full record

ArticleMalaria journal2015

Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting.

Georgia R Gore-Langton, Nfornuh Alenwi, James Mungai, Nahashon I Erupe, Katie Eves, Francis Njoroge Kimwana, David Soti, Willis Akhwale, Farah A Hassan, Elizabeth Juma and 1 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Georgia R Gore-LangtonThe MENTOR Initiative, Crawley, UK. georgia@mentor-initiative.net.
Nfornuh AlenwiThe MENTOR Initiative, Garissa, Kenya. nfornuh@mentor-initiative.net.
James MungaiThe MENTOR Initiative, Garissa, Kenya. jamesmungai2001@yahoo.com.
Nahashon I ErupeThe MENTOR Initiative, Garissa, Kenya. nerupe@yahoo.com.
Katie EvesThe MENTOR Initiative, Crawley, UK. katie@mentor-initiative.net.
Francis Njoroge KimwanaMinistry of Health, Garissa, Kenya. njoro33@yahoo.com.
David SotiMinistry of Health, Nairobi, Kenya. dsoti2002@yahoo.com.
Willis AkhwaleMinistry of Health, Nairobi, Kenya. wilak4@yahoo.com.
Farah A HassanMinistry of Health, Garissa, Kenya. fahamin76@yahoo.com.
Elizabeth JumaMinistry of Health, Nairobi, Kenya. jumaelizabeth@yahoo.com.
Richard AllanThe MENTOR Initiative, Crawley, UK. richard@mentor-initiative.net.
Ministry of Health · KEMentor · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrent day malaria cases and deaths are indicative of a lack of access to both methods of prevention, diagnosis, and treatment; an important determinant of treatment efficacy is adherence. This study is a follow up to the baseline study of adherence to artemether-lumefantrine (AL) carried out in Garissa District in 2010. The study presented evaluates any changes in adherence levels which may have occurred in the area during this period and after nearly three years of sustained use of ACT across the public health sector.

methodsThe study was carried out in Garissa County in the North Eastern Province of Kenya and included patients fitting the suspected malaria case definition and having been prescribed AL, regardless of confirmatory diagnosis. A questionnaire assessed the intake of AL via both self-reporting by the participant and observation of blister packs by the interviewer. On separate occasions exit interviews with patients and observations of prescribers were also carried out.

resultsOf the 218 participants enrolled, 195 were successfully followed up. 60% of participants were found to be adherent to the three-day AL regimen, this is 4.7% lower than the proportion of participants adherent in 2010; the result of a two-sided z-test was not significant (p = 0.23). The odds of the patient being adherent to AL increased by 65% with each additional correct statement regarding how to take AL that a patient could recall (between zero and four statements), this was the only variable significantly associated with patient adherence (p = 0.01).

conclusionSustaining the ACT adherence rates at the 2010 levels, through 2.5 years of insecurity in the study area is an achievement and suggests that if security can be improved barriers to improving health service quality and patient adherence to AL would be removed. This study, by looking specifically at anti-malarial adherence over a prolonged period and in a setting of severe conflict, provides a valuable and rare insight in to the challenges and barriers to ACT adherence in such settings.

Indexed as

Patient ComplianceAdolescentAdultAgedAged, 80 and overAntimalarialsArtemether, Lumefantrine Drug CombinationArtemisininsDrug CombinationsEthanolaminesFemaleFluorenesFollow-Up StudiesHumansKenyaMalariaAntimalarialsArtemether, Lumefantrine Drug CombinationArtemisininsDrug CombinationsEthanolaminesFluorenes

Identifiers

PMID25888895
PMCPMC4405916
OpenAlexW2019668483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.